Thomas J Herzog Selected Research

Drug Therapy (Chemotherapy)

1/2024	Molecular profiling of gestational trophoblastic neoplasia: Identifying therapeutic targets.
8/2023	Acute pulmonary complications in the setting of high risk gestational trophoblastic neoplasia and induction of chemotherapy.
7/2023	ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer.
1/2023	Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
1/2023	Overcoming the challenges of drug development in platinum-resistant ovarian cancer.
1/2023	Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.
1/2022	What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.
12/2021	ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.
12/2020	Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.
7/2020	Early diagnosis and treatment challenges of endodermal sinus tumors: A case report.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas J Herzog Research Topics

Disease

85	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 01/2002
69	Neoplasms (Cancer) 04/2024 - 03/2002
23	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 06/2003
21	Endometrial Neoplasms (Endometrial Cancer) 11/2023 - 06/2002
16	Carcinoma (Carcinomatosis) 11/2022 - 01/2002
13	Ovarian Epithelial Carcinoma 01/2023 - 01/2004
6	Disease Progression 10/2023 - 09/2003
6	Neoplasm Metastasis (Metastasis) 08/2023 - 03/2004
6	Neutropenia 02/2017 - 01/2002
6	Ascites 06/2015 - 01/2002
5	Fatigue 01/2023 - 10/2014
5	Hypertension (High Blood Pressure) 01/2017 - 11/2004
4	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 12/2004
4	Thrombocytopenia (Thrombopenia) 10/2014 - 01/2002
4	Lymphatic Metastasis 12/2004 - 06/2003
3	Nausea 01/2023 - 11/2014
3	Febrile Neutropenia 01/2017 - 01/2004
3	Infections 01/2017 - 11/2004
3	Hemorrhage 07/2014 - 08/2013
3	Wounds and Injuries (Trauma) 10/2013 - 06/2010
3	Venous Thromboembolism 11/2011 - 06/2010
2	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2024 - 08/2023
2	Fallopian Tube Neoplasms 12/2021 - 01/2017
2	Fever (Fevers) 01/2021 - 11/2014
2	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 07/2020 - 11/2004
2	Uterine Neoplasms (Uterine Cancer) 01/2020 - 07/2013
2	COVID-19 01/2020 - 01/2020
2	Leiomyosarcoma 12/2018 - 11/2008
2	Vomiting 02/2017 - 11/2014
2	Proteinuria 01/2017 - 07/2014
2	Endometriosis 01/2016 - 08/2013
2	Abdominal Pain (Pain, Abdominal) 11/2014 - 07/2014
2	Female Genital Diseases 05/2014 - 02/2013
2	Pelvic Organ Prolapse 08/2013 - 11/2012
2	Vulvar Neoplasms (Vulvar Cancer) 07/2013 - 09/2008
2	Adenocarcinoma 01/2012 - 12/2007
2	Clear Cell Adenocarcinoma 01/2009 - 12/2004
2	Hemolytic-Uremic Syndrome 04/2005 - 11/2004
2	Anemia 11/2004 - 01/2002
1	Lung Diseases (Lung Disease) 08/2023
1	Lung Injury 08/2023
1	Alopecia (Baldness) 01/2023
1	Genomic Instability 01/2023

Drug/Important Bio-Agent (IBA)

32	PlatinumIBA 10/2023 - 01/2002
17	Paclitaxel (Taxol)FDA LinkGeneric 10/2023 - 01/2002
17	liposomal doxorubicin (Doxil)FDA Link 01/2023 - 01/2002
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2010
11	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 01/2004
11	Topotecan (Hycamtin)FDA LinkGeneric 03/2011 - 01/2002
10	1-dodecylpyridoxal (PLD)IBA 11/2021 - 04/2005
8	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2004
7	Bevacizumab (Avastin)FDA Link 01/2023 - 11/2010
7	TrabectedinIBA 01/2021 - 07/2010
6	taxaneIBA 01/2017 - 08/2006
5	FANG vaccineIBA 02/2023 - 12/2020
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 06/2002
4	Hormones (Hormone)IBA 01/2020 - 06/2010
4	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 07/2004
4	Gemcitabine FDA Link 03/2010 - 01/2004
4	VaccinesIBA 05/2008 - 09/2003
4	Deoxyglucose (2 Deoxy D glucose)IBA 12/2005 - 06/2003
3	AntigensIBA 01/2023 - 07/2016
3	Monoclonal AntibodiesIBA 01/2023 - 01/2016
3	Docetaxel (Taxotere)FDA Link 03/2014 - 08/2003
3	Topoisomerase I InhibitorsIBA 05/2008 - 01/2002
2	Immune Checkpoint InhibitorsIBA 10/2023 - 12/2021
2	farletuzumabIBA 01/2023 - 01/2016
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2023
2	EpitopesIBA 01/2022 - 12/2021
2	CytokinesIBA 01/2022 - 11/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2016 - 01/2016
2	pazopanib FDA Link 03/2016 - 10/2014
2	Progestins (Progestagens)IBA 09/2015 - 01/2004
2	Phosphotransferases (Kinase)IBA 07/2013 - 02/2013
2	Etoposide (VP 16)FDA LinkGeneric 11/2004 - 11/2004
1	niraparibIBA 11/2023
1	ParaffinIBA 09/2023
1	Formaldehyde (Formol)FDA Link 09/2023
1	pembrolizumabIBA 07/2023
1	anetumab ravtansineIBA 01/2023
1	Folic Acid AntagonistsIBA 01/2023
1	MesothelinIBA 01/2023

Therapy/Procedure

59	Therapeutics 01/2024 - 01/2002
36	Drug Therapy (Chemotherapy) 01/2024 - 01/2002
28	Hysterectomy 10/2021 - 08/2004
9	Immunotherapy 10/2023 - 01/2019
9	Radiotherapy 08/2014 - 09/2003
8	Lymph Node Excision (Lymph Node Dissection) 01/2013 - 04/2002
4	Ovariectomy (Oophorectomy) 10/2021 - 04/2002
4	Laparotomy 11/2004 - 03/2004
3	Cytoreduction Surgical Procedures 12/2021 - 12/2011
3	Adjuvant Chemotherapy 01/2019 - 10/2018
3	Brachytherapy 08/2014 - 12/2011
3	Neoadjuvant Therapy 04/2014 - 09/2008
3	Adjuvant Radiotherapy 04/2009 - 10/2003
2	Precision Medicine 01/2022 - 06/2012
2	Length of Stay 06/2010 - 09/2003
2	Aftercare (After-Treatment) 01/2007 - 11/2004
2	Catheters 05/2006 - 01/2002